Randomized, double-blind, placebo-controlled trial of pregabalin for chemotherapy-induced peripheral neuropathy symptoms

Phase 3, randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) and peripheral neuropathy comparing Pregabalin (Lyrica) with Placebo (2 arms). Primary endpoint: Time to onset of moderate-severe persistent paresthesic positive symptoms of chemotherapy-induced neuropathy. Started Aug 2006; status: terminated.